DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict Disease Outbreaks EMERYVILLE, Calif., March 3, 2020 – Profusa, a digital health company that is pioneering the ...
Read More »
News & Events
For media inquiries, please contact [email protected].
Research Presented at LINC Suggests the Profusa Lumee® Oxygen Platform May Improve Clinical Management of Patients with Critical Limb Ischemia
New Insights Come as Profusa Receives CE Mark for Its Latest Generation Device, the Wireless Lumee® Oxygen Platform LEIPZIG, Germany, and EMERYVILLE, Calif., [January 30, 2020] – Profusa, a digital health company that is pioneering ...
Read More »
Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygen
Next-Generation Wireless Device May Enable Telehealth And Remote Patient Monitoring in the Future EMERYVILLE, Calif., [January 28, 2020] – Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced ...
Read More »
Potential Utility of Tissue Oxygen Sensors in Perfusion Monitoring
Novel microsensing technology that reflects microvascular perfusion and oxygen supply in tissue shows promise in patients with chronic limb-threatening ischemia.
Read More »
Injectable Body Sensors Take Personal Chemistry to a Cell Phone Closer to Reality
NEW ORLEANS, March 19, 2018 — Up until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented ...
Read More »
Health Risk-Management: The value of real-time monitoring of body chemistries
We are becoming more accustomed to continually tracking health metrics with smart wearable devices. The next step will be implantable devices, which provide real-time monitoring of body chemistry. That future is already here and will ...
Read More »
Former Senate Majority Leader William Frist, M.D., Joins Profusa’s Board
Leading Healthcare Authority and Public Health Advocate to Advise Developer of Tissue-integrated Sensors for Real-time Monitoring of Body Chemistry SOUTH SAN FRANCISCO, Calif., June 7, 2017 — Profusa, Inc. announced today that William Frist, M.D., ...
Read More »
Ben Hwang, CEO at Profusa, Interviewed by LLAMA Host Peter Bowes
Ben Hwang, Chairman and CEO at Profusa, spoke to LLAMA host, Peter Bowes, at TEDMED in California. LLAMA, ...
Read More »
Profusa, Inc. and North Carolina State University’s ASSIST Center Awarded $1.5M NIH Grant to Co-Develop Ultrathin, Wearable, Wireless, Oxygen Monitor for Patients with Peripheral Artery Disease
SOUTH SAN FRANCISCO, Calif. and RALEIGH, N.C., February 6, 2017 — Profusa, Inc. and North Carolina State University’s ASSIST Center today announced their collaboration to develop an ultrathin flexible-patch reader worn on the skin for ...
Read More »
Profusa Featured At TEDMED The Hive
Presentation by Profusa’s CEO Ben Hwang at TEDMED The Hive on Thursday, December 1, 2016. What if we can design and control our physical well being?
Read More »